Hjem
Per Bakkes bilde

Per Bakke

Dekan, Det medisinske fakultet
  • E-postPer.Bakke@uib.no
  • Telefon+47 55 58 20 87+47 992 04 032
  • Besøksadresse
    Armauer Hansens Hus
    Haukelandsveien 28
    Rom 
    407, 4. etasje
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2013. Six-minute-walk test in chronic obstructive pulmonary disease minimal clinically important difference for death or hospitalization. American Journal of Respiratory and Critical Care Medicine. 382-386.
  • 2013. Non-response in telephone surveys of COPD patients does not introduce bias. Journal of Telemedicine and Telecare. 40-44.
  • 2013. Mortality by level of emphysema and airway wall thickness. American Journal of Respiratory and Critical Care Medicine. 602-608.
  • 2013. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Medicine. 1328-1333.
  • 2013. Increased prevalence of chronic obstructive pulmonary disease in a general population. Respiratory Medicine. 1037-1045.
  • 2013. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. Respiratory Medicine. 1201-1209.
  • 2013. Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics. 263-272.
  • 2013. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Human Genetics. 431-441.
  • 2013. Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. American Journal of Respiratory and Critical Care Medicine. 51-59.
  • 2013. A comparison of nasopharyngeal and oropharyngeal swabbing for the detection of influenza virus by real-time PCR. European Journal of Clinical Microbiology and Infectious Diseases. 381-385.
  • 2012. TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respiratory Research. 10 sider.
  • 2012. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLOS ONE. 10 sider.
  • 2012. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. The International Journal of Chronic Obstructive Pulmonary Disease. 571-576.
  • 2012. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 1065-1072.
  • 2012. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. American Journal of Respiratory and Critical Care Medicine. 622-632.
  • 2012. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 1238-1247.
  • 2012. Genetic association between human chitinases and lung function in COPD. Human Genetics. 1105-1114.
  • 2012. Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open. 11 sider.
  • 2011. Quantitative CT measures of emphysema and airway wall thickness are related to DLCO. Respiratory Medicine. 343-351.
  • 2011. Polymorphisms in surfactant protein D are associated with COPD. American Journal of Respiratory Cell and Molecular Biology. 316-322.
  • 2011. Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax. 903-909.
  • 2011. High prevalence of respiratory symptoms during air travel in patients with COPD. Respiratory Medicine. 50-56.
  • 2011. Genome-wide Association Study Identifies BICD1 as a Susceptibility Gene for Emphysema. American Journal of Respiratory and Critical Care Medicine. 43-49.
  • 2011. Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 304-310.
  • 2011. Excessive costs of COPD in ever-smokers. A longitudinal community study. Respiratory Medicine. 485-493.
  • 2011. Candidate genes for chronic obstructive pulmonary disease in two large data sets. European Respiratory Journal. 255-263.
  • 2010. alpha(1)-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts. Chest. 1125-1132.
  • 2010. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nature Genetics. 200-202.
  • 2010. Transthoracic fine-needle aspiration in the aetiological diagnosis of communityacquired pneumonia. Clinical Microbiology and Infection (CMI). 909-911.
  • 2010. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 283-290.
  • 2010. Systemic inflammatory markers in chronic obstructive pulmonary disease – results from the Bergen COPD Cohort Study. European Respiratory Journal. 540-548.
  • 2010. Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal. 480-487.
  • 2010. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health and Quality of Life Outcomes.
  • 2010. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. American Journal of Respiratory and Critical Care Medicine. 353-359.
  • 2010. Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 262-268.
  • 2010. Multistudy Fine Mapping of Chromosome 2q Identifies XRCC5 as a Chronic Obstructive Pulmonary Disease Susceptibility Gene. American Journal of Respiratory and Critical Care Medicine. 605-613.
  • 2010. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics. 436-U75.
  • 2010. Healthy hire effect, job selection and inhalation exposure among young adults with asthma. European Respiratory Journal. 517-523.
  • 2010. HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer. Clinical Respiratory Journal. 168-175.
  • 2010. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 480-485.
  • 2010. Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clinical Respiratory Journal. 89-96.
  • 2010. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respiratory Medicine. 986-994.
  • 2009. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 283-290.
  • 2009. Relationships between hand-rolled cigarettes and primary lung cancer: A Norwegian experience. Clinical Respiratory Journal. 152-160.
  • 2009. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. European Respiratory Journal. 858-865.
  • 2009. Quantitative CT Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. American Journal of Respiratory and Critical Care Medicine.
  • 2009. Prevalens av hjemmerespiratorbehandling i Norge. Tidsskrift for Den norske legeforening. 2094-2097.
  • 2009. Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work, Environment and Health. 454-460.
  • 2009. Effect of reducing indoor air pollution on women’s respiratory symptoms and lung function: The RESPIRE Randomized Trial, Guatemala. American Journal of Epidemiology. 211-220.
  • 2009. Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clinical Respiratory Journal.
  • 2009. CTLA4 gene polymorphisms are associated with chronic bronchitis. European Respiratory Journal. 598-604.
  • 2009. Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Human Molecular Genetics. 2053-2062.
  • 2009. Aspects of healthcare utilisation in self-reported obstructive lung disease. Clinical Respiratory Journal. 34-41.
  • 2009. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genetics. 8 sider.
  • 2008. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine. 399-406.
  • 2008. Repeatability of health economic data in COPD. Respiratory Medicine. 1556-1562.
  • 2008. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. Clinical Respiratory Journal. 10-25.
  • 2008. No increase in response rate by adding a web response option to a postal population survey: A randomized trial. Journal of Medical Internet Research. e40.
  • 2008. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Respiratory Medicine. 1460-1467.
  • 2008. Designing studies for diagnostic tests. Clinical Respiratory Journal. 72-75.
  • 2008. Clinical data discriminating between adults with positive and negative results on bronchodilator testing. The International Journal of Tuberculosis and Lung Disease. 205-213.
  • 2008. Asthma and health-related quality of life - effect of adjusting for potential confounders. Clinical Respiratory Journal. 106-115.
  • 2007. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. American Journal of Respiratory and Critical Care Medicine. 167-173.
  • 2007. Feasible and simple exclusion criteria for pulmonary reference populations. Thorax. 792-798.
  • 2007. Exposure to environmental tobacco smoke in a general population. Respiratory Medicine. 277-285.
  • 2007. Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway. Respiratory Medicine. 1251-1257.
  • 2007. Changes in Respiratory Symptoms and Health-Related Quality of Life. Chest. 1890-1897.
  • 2007. Bronchodilator response to adrenergic (beta) (2)-agonists: Relationship to symptoms in an adult community. Respiratory Medicine. 1183-1190.
  • 2006. Post-bronchodilator spirometry reference values in adults and implications for disease management. American Journal of Respiratory and Critical Care Medicine. 1316-1325.
  • 2006. Opplæring av pasienter i riktig bruk av inhalasjonsmedisiner. Tidsskrift for Den norske legeforening. 312-314.
  • 2006. Obstruktiv lungesykdom hos barn og voksne. Presentasjon av et integrert undervisningsopplegg i allmennmedisin. UNIPED (Tromsø). 24-30.
  • 2006. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. European Respiratory Journal. 682-688.
  • 2006. Does smoking cessation improve quality of life in patients with coronary heart disease? Scandinavian Cardiovascular Journal. 11-16.
  • 2006. Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 274-280.
  • 2006. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta(2)-agonist. Pulmonary Pharmacology & Therapeutics. 272-280.
  • 2005. The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. American Journal of Respiratory and Critical Care Medicine. 61-66.
  • 2005. Scandinavian COPD research symposium. Respiratory Medicine.
  • 2005. Røykevaner blant medisinstudenter i Bergen. Tidsskrift for Den norske legeforening. 276-277.
  • 2005. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respiratory Medicine. 186-195.
  • 2005. Predictors of smoking cessation in patients admitted for acute coronary heart disease. Journal of Cardiovascular Risk. 472-477.
  • 2005. Indoor exposures and respiratory symptoms in a Norwegian community sample. Thorax. 937-942.
  • 2005. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. The International Journal of Tuberculosis and Lung Disease. 926-932.
  • 2005. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 842-847.
  • 2005. Et tverrfaglig undervisningsopplegg om obstruktiv lungesykdom i allmennpraksis. Tidsskrift for Den norske legeforening. 465-465.
  • 2005. Assessment of lung volumes in children and adolescents: comparison of two plethysmographic techniques. Clinical Physiology and Functional Imaging. 62-68.
  • 2004. Trends in symptoms of obstructive lung disease in Norway. The International Journal of Tuberculosis and Lung Disease. 1416-1422.
  • 2004. Trends in symptoms of obstructive lung disease in Norway. The International Journal of Tuberculosis and Lung Disease. 1416-1422.
  • 2004. The effect of educational level on the incidence of asthma and respiratory symptoms. Respiratory Medicine. 730-736.
  • 2004. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. European Respiratory Journal. 589-594.
  • 2004. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatrica. 1294-1300.
  • 2004. Pulmonary gas exchange and educational level: a community study. European Respiratory Journal. 583-588.
  • 2004. Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scandinavian Journal of Public Health. 411-417.
  • 2004. Interpreting and reporting results. The International Journal of Tuberculosis and Lung Disease. 1506-1509.
  • 2004. Bias in retrospective studies of trends in asthma incidence. European Respiratory Journal. 281-286.
  • 2004. Atopic and non-atopic asthma in a farming and a general population. American Journal of Industrial Medicine. 396-399.
  • 2003. Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scandinavian Journal of Public Health. 1-7.
  • 2003. Long-term changes in adult asthma prevalence. European Respiratory Journal. 468-472.
  • 2003. Factors affecting growth of FEV1. Monaldi Archives for Chest Disease. 103-107.
  • 2003. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. European Respiratory Journal. 3s-9s.
  • 2003. Does smoking affect the outcome of patient education and self-management in asthmatics? Patient Education and Counseling. 91-97.
  • 2003. Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. American Journal of Epidemiology. 558-566.
  • 2002. Occupational airborne exposure and the incidence of respiratory symptoms and asthma. American Journal of Respiratory and Critical Care Medicine. 933-938.
  • 2002. Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology. 775-781.
  • 2002. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. European Respiratory Journal. 599-605.
  • 2002. Effekter av astmaopplæring i en randomisert, kontrollert undersøkelse. Tidsskrift for Den norske legeforening. 2702-2706.
  • 2002. Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. Respiratory Medicine. 424-431.
  • 2002. Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. American Journal of Epidemiology. 572-576.
  • 2001. Relationship between occupational exposure, estimated by two job-exposure matrices, and lung function in French, Dutch, and Norwegian community studies. European Respiratory Review. 91-97.
  • 2000. Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 649-656.
  • 2000. Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 649-656.
  • 2000. Study design. European Respiratory Monograph. 128-153.
  • 2000. Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • 2000. Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • 2000. Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 1022-1025.
  • 2000. Prevention of death from asthma. International Review of Asthma. 50-58.
  • 2000. Prevention of death from asthma. International Review of Asthma. 50-58.
  • 2000. Performance of population-specific job exposure-matrices (JEM). Occupational and Environmental Medicine. 126-132.
  • 2000. Performance of population-specific Job exposure-matrices (JEM). Occup Environ Med. 126-132.
  • 2000. Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. Respiratory Medicine. 279-287.
  • 2000. Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 428-431.
  • 2000. Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 428-431.
  • 2000. Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 457-462.
  • 2000. Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 457-462.
  • 2000. Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 391-392.
  • 2000. Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 391-392.
  • 2000. Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 279-287.
  • 2000. Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 279-287.
  • 2000. I hvor stor grad snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • 2000. Et forsvarlig blikk på bupropion. Lungeforum. 113-115.
  • 2000. Et forsvarlig blikk på bupropion. Lungeforum. 113-115.
  • 2000. Comparison of respiratory symptoms questionnaires. The International Journal of Tuberculosis and Lung Disease. 83-90.
  • 2000. Comparison of respiratory symptoms questionaires. The International Journal of Tuberculosis and Lung Disease. 83-90.
  • 1999. The risks of snoring and day-time hypersomnolence in a general Norwegian population. American Journal of Respiratory and Critical Care Medicine. S:A562.
  • 1999. The association of sex, age and smoking to respiratory symptoms in a longitudinal study in western Norway. European Respiratory Journal. 19.
  • 1999. Reproducibility of indoor environment characteristics obtained in a walk through questionaire. A pilot study. Indoor Air: International Journal of Indoor Environment and Health. 26-32.
  • 1999. Relationship between two biological inflammatory markers and single-breath transfer factor for carbon monoxide (TLCO) in a general population sample. European Respiratory Journal. 133.
  • 1999. New epidemiological interpretations of the average attributable fraction from a game theoretical perspective. American Journal of Respiratory and Critical Care Medicine. S:A320.
  • 1999. Incidence and remission rates of respiratory symptoms by sex, age and smoking in a Norwegian community during twelve years. American Journal of Respiratory and Critical Care Medicine. S:A134.
  • 1999. Decreasing response to respiratory disease surveys. Norwegian Respiratory Journal. 12.
  • 1999. Comparison between two respiratory symptomquestionnaires, by sex and smoking habits. American Journal of Respiratory and Critical Care Medicine. S:A134.
  • 1999. Asthma and wheezing are increasing in repeated community surveys of adults. European Respiratory Journal. 216.
  • 1999. Acute hospital treatment of obstructive lung disease in western Norway. Norwegian Respiratory Journal. 39.
  • 1998. Applicability of the single breath carbon monoxide diffusing capacity in a Norwegian community study. American Journal of Respiratory and Critical Care Medicine. 1745-1750.
  • 1997. Transcutaneous abdominal ultrasonography in the staging of lung cancer. Thorax. 276-280.
  • 1997. Smoking and ulcer perforation. Gut. 177-180.
  • 1997. Smoking and ulcer perforation. Gut. 177-180.
  • 1997. Astma og inneklima i Hordaland. AstmaAllergi. 37.
  • 1996. Serum respiratory virus antibodies: Predictor of reduced one second forced expiratory volume in Norwegian adults. International Journal of Epidemiology. 134-141.
  • 1996. Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. European Respiratory Journal. 919-925.
  • 1996. Associations of forced expiratory volume in one second to serum total IgE and respiratory virus antibodies in subexamples of a general population. American Journal of Epidemiology. 134-141.
  • 1995. Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clinical and Experimental Allergy. 582-689.
  • 1995. Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 1158-1163.
  • 1995. Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 1158-1163.
  • 1995. Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 223-231.
  • 1995. Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 223-231.
  • 1995. Husstøvmidd sensibilisering: gir det nedsatt lungefunksjon og økt bronkial aktivitet hos voksne? Allergologen. 16-23.
  • 1994. Total and specific serum IgE levels in adults: relationship to sex, age and environemental factors. Clinical and Experimental Allergy. 530-539.
  • 1994. Total and specific immunoglobulin E-levels in a general adult population. Relationship to sex, age and environmental factors. Clinical and Experimental Allergy. 530-539.
  • 1993. Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. Norsk Epidemiologi. 8-11.
  • 1993. Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. Norsk Epidemiologi. 8-11.
  • 1993. Association of airflow impairment to level of serum IgE and number of respiratory virus antibodies in subsamples of a general population. The European respiratory journal. Supplement. 393-393.
  • 1992. Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax. 167-173.
  • 1992. Occupational airborne exposure of the general population of a Norwegian county. Scandinavian Journal of Work, Environment and Health. 44-51.
  • 1992. Non-specific challenge test for the diagnosis of asthma in a general population sample. European Respiratory Journal. 644-644.
  • 1992. Astmatiske lungesykdommer. Astma- og allerginytt. 3435-3435.
  • 1992. Allergiske sykdommer i Norge. Operative definisjoner, forekomst og risikofaktorer. Nord Med. 108-109.
  • 1991. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax. 863-870.
  • 1991. Occupational airborn exposure and respiratory disorders in a general population of Norway. European Respiratory Journal. 273-278.
  • 1991. Measurements of respiration symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease. European Respiratory Review. 436-443.
  • 1991. Bronchial responsiveness in a Norwegian community. American Review of Respiratory Diseases. 317-322.
  • 1990. Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community. Scandinavian Journal of Work, Environment and Health. 195-202.
  • 1990. Postal survey on airborne occupational exposure and respiratory disorders in Norway. Causes and consequences of non-response. Journal of Epidemiology and Community Health. 316-320.
  • 1990. Hayfever, eczema and urticaria in south-west Norway. Lifetime prevalences and association with sex, age, occupational airborne exposures and respiratory symptoms. Allergy. European Journal of Allergy and Clinical Immunology. 515-522.
Vitenskapelig foredrag
  • 2017. Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients.
  • 2008. Cognitive behavioural therapy (CBT) for anxiety and depression in COPD: A treatment option in pulmonary care.
  • 2007. Virale pneumonier hos eldre.
  • 2007. Cognitive behavioral therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease.
  • 2004. Indoor air pollutions and respiratory symptoms in a Norwegian community sample.
  • 2003. The association between indoor climate and respiratory symptoms in a general population sample.
  • 2002. Prevalence and seveity of GOLD defined COPD in adults.
  • 2002. Long term changes in self-reported symptoms and diagnoses of obstructive lung disease and heart disease in Oslo, Norway.
  • 1999. The risks of snoring and day-time hypersomnolence in a general Norwegian population. Poster.
Sammendrag/abstract
  • 2019. Repeated bronchoscopy examination of the airway microbiome. European Respiratory Journal.
  • 2017. Static hyperinflation and decline in functional capacity in COPD patients. European Respiratory Journal.
  • 2016. Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD. European Respiratory Journal.
  • 2014. Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.
  • 2012. Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. Journal of Neuroimmunology. 21-22.
  • 2010. Testing for Weak Signal. Genetic Epidemiology. 938-939.
  • 2009. How expensive is comorbidity in COPD? Respiratory Medicine. S7-S7.
  • 2008. Group cognitive behavioural therapy for anxiety, depression and sleep disturbances in patients with chronic respiratory illness. International Journal of Psychology (IJP). 16-16.
  • 2007. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Journal of Thoracic Oncology. S431-S431.
  • 2007. Cognitive behavioural therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease. Journal of Psychosomatic Research. 323-323.
  • 2004. Chronic airway symptoms and lung function among women in a rural community in Guatemala with high indoor air pollution levels. Epidemiology. S79-S80.
Vitenskapelig oversiktsartikkel/review
  • 2018. Large-scale label-free quantitative mapping of the sputum proteome. 2072-2091.
  • 2016. Participation in research bronchoscopy: a literature review.
  • 2016. Complications and discomfort of bronchoscopy: a systematic review. 9 sider.
  • 2014. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. 1022-1030.
  • 2014. Lessons from ECLIPSE: A review of COPD biomarkers. 666-672.
  • 2009. Genetikk ved kronisk obstruktiv lungesykdom. 2104-2107.
  • 2005. The incidence of adult asthma: a review. 603-612.

Se fullstendig oversikt over publikasjoner i CRIStin.